Ryan Margaret M MM

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.

Not available

S-EPMC5321073 | biostudies-literature

Comparison of expression profiles of once and three time linearly amplified samples

In order to assess the impact of three rounds of linear amplification on the technical reproducibility of gene expression measurements, we performed twelve microarray experiments. We analysed mouse RNA from cortex, cerebellum and liver from one individual. One RNA sample of 5Âµg from each of the thr...

ORGANISM(S): Mus musculus

2010-06-08 | E-GEOD-21389 | biostudies-arrayexpress

Glioma GWAS summary statistics

Meta-analysis association statistics from case-control analysis (includes imputed SNPs)

EGAD00010001657 | EGA

Summary statistics from genome-wide association study in glioma of 12,488 cases and 18,169 controls.

Genome-wide association studies (GWAS) have transformed our understanding of glioma susceptibility, but individual studies have had limited power to identify risk loci. We performed a meta-analysis of existing GWAS and two new GWAS, which totaled 12,488 cases and 18,169 controls. We identified five ...

EGAS00001003372 | EGA

Glioma GWAS summary statistics DAC

Data Access Committee EGAC00001001116

EGAC00001001116 | EGA

The Germline and Somatic Origins of Prostate Cancer Heterogeneity.

Not available

S-EPMC12046336 | biostudies-literature

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial.

Not available

S-EPMC9467680 | biostudies-literature

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.

Not available